FY2025 · ended Dec 31, 2025 · Revenue $4.51M, +44.9% YoY · Filed Apr 9, 2026
Healthy Extracts Inc. (HYEX) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $4.5 million and a net loss of $881,119. As of Jun 30, 2026 it held $189,958 in cash and investments and $425,925 in total debt.
Revenue (TTM)
$6.29M
+84.1% vs year-ago TTM
Net income (TTM)
$-878,866
-107.0% vs year-ago TTM
Operating cash flow (TTM)
$500,267
+191.9% vs year-ago TTM
Free cash flow
$-415,749
-4.3% vs prior year
EPS
—
Dividend per share
None
Shares outstanding
16.89M
+465.0% vs prior year
Net cash
$-235,967
as of Jun 30, 2026
Operating margin
-4950.4%
FY 2018
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- HYEX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Henderson, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1630176
- Former names
- HEALTHLY EXTRACTS INC. (until Mar 11, 2021); GREY CLOAK TECH INC. (until Feb 19, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $4.5M | $3.1M | $2.5M | $2.3M | $1.7M |
| Net income | -$881,119 | -$840,671 | -$2.5M | -$983,121 | -$2.0M |
| Operating cash flow | $165,520 | $281,968 | -$415,749 | -$390,621 | -$901,298 |
| Free cash flow | — | — | -$415,749 | -$398,608 | — |
| Total assets | $27.8M | $2.4M | $2.6M | $2.8M | $3.0M |
| Total liabilities | $3.8M | — | — | — | — |
| Stockholders' equity | $24.0M | $410,377 | $954,590 | $1.9M | $2.5M |
| Cash and investments | $146,935 | $112,020 | $19,441 | $65,651 | $222,098 |
| Total debt | $516,195 | $9,222 | $74,452 | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 18, 2026 | Sep 13, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 24, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change
|
May 18, 2026 | May 15, 2026 |
All 195 Healthy Extracts Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.